These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1716720)

  • 1. Evaluation of the effect of pharmacologic agents on crush-avulsion arterial injuries: a scanning electron microscopy study.
    Savoie FH; Cooley BC; Gould JS
    Microsurgery; 1991; 12(4):292-300. PubMed ID: 1716720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scanning electron microscopy of crush/avulsion arterial trauma:effect of heparin and aspirin administration.
    Cooley BC; Ruas EJ; Wilgis EF
    Microsurgery; 1987; 8(1):11-6. PubMed ID: 3586988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anticoagulation and inhibition of platelet aggregation on arterial versus venous microvascular thrombosis.
    Li X; Cooley BC
    Ann Plast Surg; 1995 Aug; 35(2):165-9; discussion 169-70. PubMed ID: 7486739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time of low-dose acetylsalicylic acid administration influences in vivo platelet function and thrombus formation following arteriotomy and intimectomy; an experimental study in small arteries of rabbits.
    Salemark L; Wieslander JB; Dougan P; Arnljots B
    Microsurgery; 1990; 11(3):209-14. PubMed ID: 2215187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombodynamics of microvascular repairs: effects of antithrombotic therapy on platelets and fibrin.
    Shi G; Meister D; Daley RA; Cooley BC
    J Hand Surg Am; 2013 Sep; 38(9):1784-9. PubMed ID: 23891176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis.
    Petzold T; Thienel M; Konrad I; Schubert I; Regenauer R; Hoppe B; Lorenz M; Eckart A; Chandraratne S; Lennerz C; Kolb C; Braun D; Jamasbi J; Brandl R; Braun S; Siess W; Schulz C; Massberg S
    Sci Transl Med; 2016 Nov; 8(367):367ra168. PubMed ID: 27903864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs.
    Lam JY; Chesebro JH; Steele PM; Heras M; Webster MW; Badimon L; Fuster V
    Circulation; 1991 Aug; 84(2):814-20. PubMed ID: 1830520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ticlopidine and other antithrombotics on the venous thrombosis induced by endothelial damage of jugular vein in rats.
    Morishita K; Wada M; Kumada T; Tanaka T; Tomikawa M; Iwamoto M
    Thromb Res; 1991 Aug; 63(3):373-84. PubMed ID: 1957278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
    Merhi Y; Bernier J; Marois Y; Guidoin R
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the antithrombotic effects of dextran 40 following microarterial trauma.
    Salemark L; Wieslander JB; Dougan P; Arnljots B
    Br J Plast Surg; 1991 Jan; 44(1):15-22. PubMed ID: 1704269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery.
    Umemura K; Nishiyama H; Kikuchi S; Kondo K; Nakashima M
    Thromb Haemost; 1996 Nov; 76(5):799-806. PubMed ID: 8950793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries.
    Chen LE; Seaber AV; Korompilias AV; Urbaniak JR
    Microsurgery; 1995; 16(10):661-5. PubMed ID: 8676728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
    Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
    Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.
    Haskel EJ; Adams SP; Feigen LP; Saffitz JE; Gorczynski RJ; Sobel BE; Abendschein DR
    Circulation; 1989 Dec; 80(6):1775-82. PubMed ID: 2513145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.